The pet food company is pivoting to pharmaceuticals through the deal with the Canadian specialty pharmacy operator.

The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical contract ...

The future of pharmaceutical investment lies in the convergence of ESG principles with a strong emphasis on positive social ...

This is the latest sign of global healthcare giants doubling down on the market in recent years. Experts noted on Monday that ...

According to NSE bulk deal data, Vanguard Emerging Markets Stock Index Fund A Series of VIEIF purchased 0.83 million shares ...

Jim Cramer, host of Mad Money, expressed his frustration on March 19 about how investors often get caught up in discussions ...

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF ...

Gas companies are in focus on Monday, following proposed regulatory changes for long-haul natural gas transportation tariff ...

Retired scientists criticise safety deficiencies and regulatory oversights in pharmaceutical plant accident investigation, calling for improved standards.

To avoid overlaps, the industry is calling for aligning MDR/IVDR with the EU's digital frameworks, pharmaceutical regulations ...

CCI investigates cartel cases in health and pharma sector, signs global agreements, introduces new mechanisms to combat ...

Needham & Company LLC reiterated their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research note released on Friday,Benzinga reports. The brokerage currently has a ...